Alan J. Rosenbloom
- Hepatology top 10%
- Liver Disease and Transplantation 3
- Immunology top 10%
- Immune Response and Inflammation 4
-
- Alcoholism and Thiamine Deficiency 2
-
- Microfluidic and Capillary Electrophoresis Applications 5
-
- Drug-Induced Hepatotoxicity and Protection 2
- Antibiotics Pharmacokinetics and Efficacy 2
-
- Diet and metabolism studies 2
-
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 2
- Co-authors
- David M. SipeRobert P. DevatyW. J. ChoykeY. ShishkinHua ZhongAnna LokshinMichael R. ShurinGalina V. Shurin
- Partner nations
- United StatesChinaCanada
In The Last Decade
Alan J. Rosenbloom
20 papers receiving 677 citations
Peers
Comparison fields: 5 of 102
- Hepatology 103
- Immunology 225
- Critical Care and Intensive Care Medicine 47
- Epidemiology 161
- Neurology 52
Countries citing papers authored by Alan J. Rosenbloom
This map shows the geographic impact of Alan J. Rosenbloom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan J. Rosenbloom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan J. Rosenbloom more than expected).
Fields of papers citing papers by Alan J. Rosenbloom
This network shows the impact of papers produced by Alan J. Rosenbloom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan J. Rosenbloom. The network helps show where Alan J. Rosenbloom may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alan J. Rosenbloom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 4 | |
| 2 | 2009 | 4 | |
| 3 | 2009 | 3 | |
| 4 | 2007 | 106 | |
| 5 | 2006 | 6 | |
| 6 | 2005 | 32 | |
| 7 | 2005 | 23 | |
| 8 | 2005 | 62 | |
| 9 | 2004 | 83 | |
| 10 | 2004 | 25 | |
| 11 | 2003 | 2 | |
| 12 | 2002 | 1 | |
| 13 | 2001 | 74 | |
| 14 | 1999 | 35 | |
| 15 | 1995 | 26 | |
| 16 | 1995 | 138 | |
| 17 | 1991 | 6 | |
| 18 | Management options in fulminant hepatic failure. | 1991 | 12 |
| 19 | Emerging treatment options in the alcohol withdrawal syndrome. | 1988 | 32 |
| 20 | 1986 | 21 |
About Alan J. Rosenbloom
Alan J. Rosenbloom is a scholar working on Hepatology, Immunology and Pharmacology, having authored 20 papers that have together received 695 indexed citations. Recurring topics across this work include Microfluidic and Capillary Electrophoresis Applications (5 papers), Immune Response and Inflammation (4 papers), Liver Disease and Transplantation (3 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Diet and metabolism studies (2 papers), Alcoholism and Thiamine Deficiency (2 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). The work is most often cited by research in Hepatology (103 citations), Immunology (225 citations) and Critical Care and Intensive Care Medicine (47 citations). Alan J. Rosenbloom has collaborated with scholars based in United States, China and Canada. Frequent co-authors include David M. Sipe, Robert P. Devaty, W. J. Choyke, Y. Shishkin, Hua Zhong, Anna Lokshin, Michael R. Shurin, Galina V. Shurin, Irina L. Tourkova and Michael R. Pinsky. Their work appears in journals such as JAMA, Clinical Cancer Research and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.